Return to homepagePandemic Pact

Development of antibody-based technology for the treatment of COVID-19-infection

  • Funded by The Research Council of Norway (RCN)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $440,000

  • Funder

    The Research Council of Norway (RCN)

  • Principal Investigator

    N/A

  • Research Location

    Norway

  • Lead Research Institution

    NORIMUN AS

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract